From: Predicting the prognosis, immune response, and immunotherapy in head and neck squamous cell carcinoma using a novel risk model based on anoikis-related lncRNAs
LncRNA
Coefficient
CYTOR
1.076602309
Z97200.1
− 1.047843038
RAB11B-AS1
− 0.725763181
LINC02084
− 0.837969986
EMSLR
0.5142609
LINC01503
0.462273641
AC015878.1
0.8283574